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Diagnosis and Treatment Plan for
Gingival Diseases and Conditions
Anahita Punj and Manav Chaturvedi
Abstract
The prevalence of gingival and periodontal disease is manifold and has not been
highlighted much due to its asymptomatic and milder symptoms. It is usually given
its due importance when the gingival disease progresses to advanced periodontal
disease, displays symptoms of dull pain and tooth mobility, and is associated with
pus discharge. The starting point of periodontal disease is usually gingival disease
which is a reversible condition. It is therefore necessary to diagnose gingival dis-
eases at an early stage to prevent its progression to irreversible periodontal disease.
The diagnosis of gingival disease becomes cumbersome due to its similarity in the
presentation of signs and symptoms. Gingival diseases can occur due to microbial
attack from the plaque biofilm which is usually bacterial in nature. There are other
viral, fungal, and immune-mediated mechanisms which can result in gingival dis-
eases. Some systemic conditions also influence the gingiva which allows for diag-
nosing systemic diseases and treating these conditions appropriately. It is said that
oral cavity is the mirror of the body, and in that sense the gingiva is the biggest
surface where any changes or manifestations could be observed.
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1. Introduction
The gingiva or commonly referred to as gums surround and protect the teeth
(Figure 1). Gingival diseases by namesake denote to the diseases affecting the
gingival tissues. These diseases have burdened the human race since the early
civilization, and this is proof enough to gauge the importance of diagnosing gingival
diseases and treating them. Gingival disease if left untreated can progress to peri-
odontal tissues and result in periodontal disease which is easier to diagnose probably
due to its chronic and severe nature as compared to gingival disease. No wonder
periodontal disease has been mentioned in the literature of ancient Egypt and a step
toward preventing it by means of oral hygiene practices deserves its mention in the
ancient scriptures [1].
2. Gingival disease terminology
The gingival disease terminology and classification has undergone many
changes, and the current classification given at the World Workshop in 2017
1
classifies gingival condition in health and disease under three broad categories of
health, dental biofilm-induced gingivitis, and non-dental biofilm-induced gingival
disease [3] (Table 1).
Figure 1.
The diagnosis of any disease is based on a proper documentation of case history which requires precise
identification of signs and symptoms of disease and also any underlying medical disease/condition which may
influence the same. The next step is to correlate clinical, pathological, laboratory and radiological findings. This
sequence of steps also holds true for gingival diseases. This chapter attempts to focus on the minute differences in
the diagnosis of gingival diseases which becomes cumbersome due to a simple fact that any infection or
inflammation usually results in swelling up of the gingiva, bleeding, or formation of ulcers or vesicles. Such
symptoms could be due to a single to multiple etiologic agents corresponding to varied diagnoses and treatment
regimens [2].
Periodontal health and gingival health Dental biofilm-induced gingivitis Non-dental
biofilm-induced
gingival disease
Clinical
gingival
health on an
intact
periodontium
Clinical gingival health on a
reduced periodontium
Associated
only with
dental
biofilm
Mediated
by
systemic
or local
risk
factors
Drug-
influenced
gingival
enlargement
Genetic/
development
disorders
Stable
periodontitis
Non-
periodontitis
Specific
infections and
inflammatory and
immune
conditions
Reactive
processes
Neoplasms
Endocrine,
nutritional, and
metabolic
diseases
Traumatic lesions
Gingival
pigmentation
Table 1.
Classification of periodontal health, gingival disease, and condition [3].
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2.1 Diagnosis of plaque-induced gingivitis
Gingivitis per se refers to the inflammation of the gingival tissues and is labeled
with different diagnostic terms based on the etiology and clinical presentation to aid
in formulation of the best-suited treatment. As mentioned above, the broad etio-
logic factors which result in gingival disease is the dental biofilm, which contain
microbes, causing a microbial attack on the gingiva resulting in a dysbiosis
amounting to a host response manifested in the form of the inflammatory disease
called plaque-induced gingivitis. The plaque microbes have an influence on the
gingiva depending upon its quantity and quality of pathogens present. Although the
increased plaque burden is almost always associated with gingivitis, there are
instances where paucity of plaque can again result in gingivitis due to the effect of
modifying factors which make the host response more accentuated and exaggerated
as they tend to have a more systemic affect than a local one [2, 4]. These modifying
factors include few systemic conditions, factors which increase plaque accumula-
tion and influence of drugs on gingiva. How these factors can affect gingivitis is
summarized in Table 2.
Factor Effect on gingiva Signs and
symptoms for
diagnosis
Diagnosis Treatment [5]
Bacterial
dental biofilm
only
Microbial attack
mounts a host
response in the form
of inflammation
Mild redness with
or without broken
line of bleeding
Incipient gingivitis OHI
Mild changes in
color and texture of
the gingiva
Mild gingivitis OHI +/OP
Glazing redness,
edema,
enlargement,
bleeding on
probing
Moderate gingivitis OHI + OP
Overt redness and
edema and
bleeding on
palpation rather on
probing
Severe gingivitis
Potential modifying factors of plaque-induced gingivitis
Systemic conditions
Sex steroid
hormones
(estrogen and
progesterone)
(1) Puberty
Exaggerate the host
inflammatory
response in the
presence of minimal
plaque
Bleeding on
probing or bleeding
with toothbrushing,
mild to moderate
redness
Diagnostic term
not given as not
seen frequently in
population and if
present can be
diagnosed as
gingivitis
associated with
puberty
OHI + OP
(2) Menstrual
cycle
Exaggerates the host
inflammatory
response in the
presence of minimal
plaque
Mild redness,
edema based on
severity of
inflammation seen
during the
menstrual cycle
Diagnostic term
not given as not
seen frequently in
population and if
present can be
diagnosed as
gingivitis
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Factor Effect on gingiva Signs and
symptoms for
diagnosis
Diagnosis Treatment [5]
associated with
menstrual cycle
(3) Pregnancy The hormones
exaggerate the host
inflammatory
response in the
presence of minimal
plaque
Deep gingival
probing depths,
bleeding on
probing or bleeding
with toothbrushing,
and elevated
gingival crevicular
fluid flow in
pregnancy
Pregnancy-
associated
gingivitis
(4) Oral
contraceptives
The high-dose
hormones in the
pills exaggerate the
host inflammatory
response in the
presence of minimal
plaque; low dose
does not have much
effect
Mild redness,
edema based on
severity of
inflammation seen
after 1 to 3 months
of use
Currently the dose
of oral
contraceptives is
low; hence
diagnostic terms
have been removed
OHI + OP +
reduction of high-
dose oral
contraceptive
Low-dose
contraceptive does
not require any
change
Hyperglycemia High blood glucose
levels increase the
pathogenic bacteria
and also form more
AGE which affect
collagen turnover
and healing
Signs of
inflammation of
gingivitis + high
blood glucose levels
Gingivitis
associated with
diabetes mellitus
OHI + OP +
maintenance of
blood glucose levels
by diet restriction/
exercise/
medication
Leukemia Increases number of
WBCs which
accumulate in the
gingival tissues and
decreases number of
platelets which
causes bleeding
Cervical
lymphadenopathy,
petechiae, ulcers
seen in the mucosa,
bleeding on slight
provocation,
swollen, glazed,
spongy gingiva, red
to deep purple color
of gingival lesions
Gingivitis
associated with
acute/chronic
leukemia
Treat leukemia +
symptomatic
treatment for
gingivitis with
careful OHI and OP
to prevent
excessive bleeding
Smoking Direct smoking can
cause
vasoconstriction of
gingival vasculature
No redness, edema,
or swelling present.
Color may change
to blue and pale
pink. No gingival
changes and pocket
depths increase
when lesions
progress to
periodontitis
No gingivitis Smoking cessation
Malnutrition Deficiency of
vitamin C affects
crosslinking of
collagen
Bleeding on
probing, mobility,
and swollen gums
in severe cases with
minimal plaque
Scurvy Vitamin C
supplementation +
OHI + OP
Oral factors enhancing plaque accumulation
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2.2 Tools used for gingival diagnosis
The crude tools used are a questionnaire/interview to collect important aspects
of the patient demographics, medical history, current medications, and habits. The
next step involves patient examination starting from extraoral structures to any
abnormal intraoral findings to specific examination of the gingiva. The gingival
disease is visually examined for clinical signs and symptoms using a mouth mirror
under ambient lighting of the dental chair, cotton/gauze to dry the tissues, and
sometimes the use of three-way air water syringe to wash way the debris for better
inspection. Changes in color, contour, consistency, texture, size, position, etc. are
Factor Effect on gingiva Signs and
symptoms for
diagnosis
Diagnosis Treatment [5]
Prominent
subgingival
restoration
margins
Roughness and
closeness of these
restorations to
gingival tissue cause
accumulation of
plaque bacteria and
irritation
Localized mild
redness, bleeding
on probing, slight
edema in area of
restoration
Gingivitis due to
faulty restoration
Correction of
restoration +
OHI + SRP
Hyposalivation Decreased saliva
causes sticking of
bacteria on tooth
surfaces
Dental caries, taste
changes, halitosis,
mucosal and
gingival dryness,
and gingival
inflammation
Gingivitis
associated with
hyposalivation
OHI + OP+ salivary
substitutes
Drug-influenced gingival enlargements
Phenytoin,
sodium
valproate
Drugs and plaque
cause fibroblasts to
increase production
of collagen and
extracellular
connective tissue
Onset after
3 months of drug
intake, common in
anterior gingiva,
gingival size
increases which
starts from
interdental papilla
and may extend to
the margin and
attached gingiva in
severe cases.
The enlarged areas
are firm to soft
depending upon the
presence of gingival
inflammation
Drug-influenced
mild gingival
enlargement (if
only papilla is
involved)
Drug-influenced
mild gingival
enlargement (if
papilla and margin
is involved)
Drug-influenced
mild gingival
enlargement (if
papilla, margin,
and attached
gingiva is
involved)
OHI + OP+ drug
substitution if
required, followed
by gingivectomy to
correct enlarged
gingival tissues
Nifedipine,
amlodipine,
verapamil,
diltiazem,
felodipine
Cyclosporine
OHI, oral hygiene instruction, OP, oral prophylaxis.
Table 2.
Diagnosis based on etiology, modifying factors, and clinical features [2, 4].
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Advanced
diagnostic aid
for gingival
disease
Mechanism/working Inference
Periotemp probe Detects the difference in subgingival
temperature which is reflected by red or
green light
Red light indicates future periodontal
breakdown and increase in
periopathogens
New generation
of periodontal
probes
First-generation Detects pocket depth using traditional
probes
Second-generation Pressure-sensitive probe with uniform
pressure
Third-generation Pressure-sensitive and captures data on
computer
Fourth-generation Uses 3D technology to detect pocket
Fifth-generation Uses 3D technology and ultrasound to
detect pocket
Advances in
radiography
Use of charged-coupled device,
complementary metal oxide
semiconductor, and cone beam-
computed tomography allow digital
recording
These are used to detect bone loss and
bone defects in 2D and 3D for
periodontal defects rather than gingival
diseases
Advances in
microbial
culturing
High-performance liquid
chromatography
Can detect bacterial cell wall
components
Flow cytometry Can detect various bacteria
Latex agglutination test Can detect pathogenic antigen, proteins,
and antibody by agglutination reaction
Direct and indirect immunofluorescence Can detect pathogenic antigen, proteins,
and antibody by agglutination and
adding fluorescent dyes
Enzyme-linked immunosorbent assay Evalusite can detect P. gingivalis,
P. intermedia, and
A. actinomycetemcomitans
Nucleic acid and DNA checkerboard
hybridization techniques
Detects microbes based on matching of
unknown sample with known
hybridization technique of nuclei acid/
DNA
DNA probe Omnigene can detect P. gingivalis,
P. intermedia, A. actinomycetemcomitans,
E. corrodens, C. rectus, F. nucleatum
Perioscan uses BANA (N-benzoyl-DL
arginine naphthylamide) hydrolysis
carried out by trypsin-like protease
Detects trypsin-like protease releasing
bacteria, such as P. gingivalis,
T. denticola, and T. forsythus
IAI Pado Test 4.5 RNA probe test kit uses
oligonucleotide probes complementary
to conserve fragments of the 16S rRNA
gene that encodes the rRNA
Detects A. actinomycetemcomitans,
P. gingivalis,Tannerella forsythia, and
T. denticola
MyPerioPath is a DNA test and uses
saliva samples
To identify the type and concentration
of periodontal bacteria
Advances in
biochemical test
kits
Perio-Check Detects neutral proteases like
collagenases in GCF (gingival crevicular
fluid)
6
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noted. This is followed by palpation of the gingiva for any spontaneous bleeding,
pain, discharge, blanching, consistency (by checking the resiliency of tissues on
applying pressure), and pitting edema. The UNC-15 or the Michigan O periodontal
probe with William’s marking is used to check for bleeding on probing, subgingival
faulty restorative margins, and the presence of deeper than 5-mm pockets which is
the critical probing depth to differentiate between gingivitis and periodontitis.
Apart from these traditional tools used, advanced diagnostic aids have been intro-
duced to further confirm the presence of gingival disease (Table 3) [5, 6].
2.3 Diagnosis of non-plaque-induced gingival diseases
Apart from plaque-induced gingivitis, it is imperative to diagnose and differen-
tiate the non-plaque-induced gingival diseases and conditions to provide appropri-
ate treatment and to avoid overtreatment. The etiology of non-plaque-associated
gingival disease is usually related to some genetic defect or systemic disorder. In
many instances the oral lesions precede the extraoral findings and can help in
diagnosing a disease which could affect the full body. Therefore, while diagnosing
these conditions, we need to look for other associated conditions to arrive at a
correct diagnosis. Table 4 attempts to highlight the clinical features to help arrive at
a diagnosis [7–11].
Advanced
diagnostic aid
for gingival
disease
Mechanism/working Inference
Prognos-Stik: detects serine proteinase
elastase in GCF
Shows active disease sites
PocketWatch: detects aspartate
aminotransferase in GCF
Differentiates active and non-active sites
of disease
PerioGard: detects aspartate
aminotransferase in GCF
Differentiates active and non-active sites
of disease
Perio 2000: detects volatile sulfur
compounds
To detect halitosis
Toxicity prescreening assay (TOPAS) Detects bacterial toxins and proteins
Dipstick Detects (matrix metalloproteinase)
MMP-8 in GCF
Integrated microfluidic platform for oral
diagnostics (IMPOD)
Saliva-based detection of MMP-8
Oral fluid nanosensor test (OFNASET):
saliva-based detection of (interleukin)
IL-1, IL-8
Used for detection of salivary
biomarkers for oral cancer
Electronic taste chip (ETC) Detects C-reactive protein which is an
important biomarker for inflammation
Genetic tests Genetic periodontitis susceptibility trait
(PST) test
Detects IL-1 polymorphism
MyPerioID Saliva-based detection of genetic
susceptibility
Table 3.
Diagnostic tools for gingival disease [5, 6].
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C Cr Cs T S P L Lab & H/P Add Sym D Rx
G Flat or
rounded
Firm and
resilient
Loss of stippling ++ Coronal to CEJ Gingival enlargement Excisional biopsy shows
fibrous connective tissue
Hereditary gingival
fibromatosis
Gingivectomy to contour
the topography + OHI
P-R/B-
Br
Blunted Soft and
friable
Ulcerative  Varies from
papillary
destruction to
beyond
mucogingival
junction
Gingival ulceration Bacterial culture for
various bacteria types
such as Treponema,
Selenomonas,
Fusobacterium, and
Prevotella intermedia.
H/P Loss of the
epithelium in ulcerated
areas
Loss of taste, woody
sensation in teeth
and feeling of
extruded teeth
accompanied with
underlying risk
factors such as poor
oral hygiene and
systemic conditions
Necrotizing periodontal
disease
Debridement of local
factors + CHX+
amoxicillin and
metronidazole
FR/W No change Soft and
edematous
Ulcerative/white
pseudomembranous
+ No change Erythematous Bacterial culture for
Neisseria gonorrhoeae
Pharyngitis and
lymphadenopathy.
Other sites: urethra,
anus, cervix, oral
mucosa
Gonorrhea Systemic antibiotic
therapy
FR No change Edematous Loss of stippling
and ulceration with
whitish membrane
+ No change Chancre (rare) Bacterial culture for
Treponema pallidum,
followed by serologic
reaction tests
Genital and skin
lesions
Syphilis Systemic antibiotic
therapy
R-Gy
patches
No change Firm Nodular/papillary
proliferation
+ No change Nodular/papillary
proliferation
Positive delayed
hypersensitivity
(tuberculin) skin
reaction to purified
protein derivative (ppd),
isolation of
mycobacterial
antigen from bacterial
cultures, and
demonstration of acid-
fast mycobacteria in
clinical specimens.
H/P: characteristic
multinucleated giant cells
Commonly
associated with lung
infections.
Involves floor of the
mouth, extraction
sites, and lymph
nodes
Tuberculosis Regimens of multiple
antibiotics like isoniazid,
rifampicin,
pyrazinamide, or
ethambutol
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and granulomas are
diagnostic features
RP Rounded Soft Erythematous patch Culture for streptococcal
strains. Biopsy
Upper respiratory
infections
Streptococcal gingivitis OHI+ antibiotics
RP No change Soft and
ulcerative
Small vesicles/
fibrinous coated
ulcer
– Blunted papilla
sometimes
Painful ulcers after
vesicle rupture
Skin lesions, low-
grade fever
Hand, foot and mouth
disease
Supportive treatment to
correct fever and pain
RP Flat and
rounded
Soft and
edematous
Ulcerated, loss of
stippling
+ Coronal or apical
to CEJ
Lymphadenitis,
fever, malaise
Primary herpetic
gingivostomatitis
Acyclovir and spirin/
paracetamol, fluids.
Dyclonine hydrochloride
0.5% for anesthesia
RP Flat and
rounded
Soft and
edematous
Ulcerated + Attached
gingival and hard
palate
Rarely required.
If needed fluorescent
staining is more
sensitive.
HSV isolation of a virus
in tissue.
Culture is the most
positive method of
identification.
Scraping made from the
base of the lesion and
stained with giemsa.
H/P: Wright’s or
Papanicolaou stain and
shows syncytium and
ballooning. Degeneration
of the nucleus
Fever Recurrent intraoral
herpes simplex
Acyclovir and aspirin/
paracetamol, fluids.
Dyclonine hydrochloride
0.5% for anesthesia
BR No change Soft Vesicular +/ Diffuse
erythema and
isolated small
vesicles that
rupture quickly
leaving
ulcerations
Lesions on skin and
mucosa
Fluorescent-antibody
staining of smears using
fluorescein-conjugated
monoclonal antibodies is
more reliable than
routine cytology
Fever, malaise, and
skin rash
Chicken pox (Varicella) Acyclovir/valacyclovir
for healing and reducing
acute pain.
Systemic corticosteroids
to prevent postherpetic
neuralgia,
combination of
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intralesional steroids and
local anesthetics to
decrease healing time
and prevent postherpetic
neuralgia and application
of capsaicin
R
patches
+W
halo
Blunt or
rounded
Soft and
friable
Ulcerated — Unilateral
vesicles which
rupture
Necrosis of
periodontium and
alveolar bone
Culture Skin lesion Shingles (herpes
zoster)
Oral acyclovir 800 mg
five
times a day, famciclovir
500 mg three times a
day, or
valacyclovir 500 mg
three times a day
Pi No change Soft Papules ++ Raised nodular
or popular
lesions
Mucosal lesions are
rare
Discrete papules on
skin of face and
trunk and in genital
areas
Molluscum contagiosum
virus
Cryotherapy/laser
G No change Firm Exophytic and
verrucous
++ Exophytic
papillomatous,
verrucous or flat
lesions
Squamous cell
papilloma, condyloma
acuminatum, verruca
vulgaris, focal epithelial
hyperplasia
Surgical removal, laser
ablation, cryotherapy,
and topical application
of keratinolytic agents.
For smaller lesions,
topical application of
25% podophyllum resin
to reduce the size.
Intralesional injection of
interferon-α
1,000,000 iu/cm2 once
weekly and
subcutaneous injections
3,000,000 iu/cm2 twice
weekly
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W-R No change Soft and
resilient
Scrapable lesion +/ Pseudomembrane/
erythematous/plaque-
like/ nodular
H/P: culture of infected
tissues or exudates on
Sabouraud’s dextrose
agar or other appropriate
media
Oral involvement is
secondary to serious
systemic infection
Candidiasis Topical antifungal
medications, nystatin,
and amphotericin b
BR Rounded Soft and
friable
Chronic vegetating
painful ulcer
++ Nodular, papillary, or
granulomatous
lesions
Biopsy of infected tissue
shows small oval yeasts
within macrophages and
reticuloendothelial cells
as well as chronic
granulomas, epithelioid
cells, giant cells, and
occasionally caseation
necrosis
Cavitation of the
lung and
dissemination of the
organism
to the liver, spleen,
adrenal glands, and
meninges
Histoplasmosis Ketoconazole or
itraconazole for 6–
12 months
RP Violaceous
marginal
gingiva in
early stage
Soft and
friable
Necrosis and
covered with
pseudomembrane
in advanced cases
 Lesions are necrotic
and covered by
pseudomembrane
Systemic
involvement is
present. Late stage
involves destruction
of alveolar bone and
facial muscles
Aspergillosis Systemic antifungals
R+ W
streaks
Normal Soft Lichenoid reaction No
change
Lichenoid-like
reaction
Patch test by placing
aluminum disks with
known allergens for
48 hours on hairless skin
and wait for any
inflammation as a
positive test.
H/P: chronic
inflammatory reaction
with lichenoid
infiltration of
lymphocytes
Contact allergy Topical corticosteroids
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R Velvety texture + Seen in anterior
maxillary gingiva
Plasma cells in lamina
propria
Plasma cell gingivitis Topical corticosteroids
R-W Soft and
friable
Smooth or
disrupted
— Round lesion with
central red area or
pale pink surrounded
by red periphery
Biopsy
an epidermal pattern
characterized by
lichenoid vasculitis and
intraepidermal vesicles
and a dermal pattern
characterized by
lymphocytic vasculitis
and subepidermal
vesiculation
Skin lesions
symmetrically
present on distal
extremities and
moving proximally
Hand, face, elbow
and knees
Erythema multiforme Anesthetic mouthwash,
corticosteroids in severe
cases, and acyclovir if
associated with HSV
RP-W Normal Soft and
friable
Smooth and loss of
stippling
No
change
Lesions on free
and attached
gingiva
Desquamative
gingivitis with
vesiculobullous
lesions which rupture
ELISA to detect
circulating antibody to
desmoglein 1 and 3.
Histopathology:
suprabasilar acantholysis
may be observed
Bullous lesions on
skin
Pemphigus vulgaris Prednisolone usually
given in dosages of 1–
2 mg/kg/d and later 
R area Normal Soft Smooth and loss of
stippling
— Positive
Nikolsky sign:
rubbing the
gingiva forms
bulla
Desquamative lesions
with bulla formation
Histopathology:
circulating antibodies not
always found by indirect
immunofluorescence
Scarring in ocular
lesions
Pemphigoid Systemic corticosteroids
R-W
streaks
Normal Soft and
resilient
Smooth and
ulcerative
No
change
Papular, reticular,
plaque type or bullous
lesions
Hyperkeratosis and saw
tooth-shaped rete pegs
Skin lesions Lichen planus Topical corticosteroids
or intralesional steroids
like 0.05% fluocinonide
(Lidex) and 0.05%
clobetasol (temovate)
R and
W
striae
Smooth and
ulcerative
/+ Central atrophic area
with small white dots
surrounded by white
striae
Hyperorthokeratosis
with keratotic plugs,
atrophy of the rete
ridges, and liquefactive
Red butterfly-
shaped
photosensitive,
scaly, macules on
Lupus erythematosus Systemic
immunosuppressant and
protection from sunlight
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degeneration of the basal
celllayer
the nose bridge and
cheeks
Pl Normal Soft ++ Cobblestone
appearance of mucosa
and linear ulceration
Histopathology Intestinal pain, anal
fissures, diarrhea,
and labial
enlargement
Crohn’s disease Steroids and
immunosuppressants to
decrease progression
RP Soft and
friable
Loss of stippling ++ Gingival
recession
Nodules and
ulceration.
Loosening of teeth
Hyperglobulinemia, an
elevated level of serum
angiotensin-converting
enzyme, evidence of
depressed cellular
immunity.
H/P: noncaseating
epithelioid
granulomas in more than
one organ system
Swelling of salivary
glands
Sarcoidosis Systemic steroids and
anti-inflammatory
agents
Pi Normal Fibrous Smooth + Exophytic smooth
masses
H/P: bundles of collagen
covered with the
epithelium
Fibrous epulis Excision and curettage
RP Normal Fibrous Smooth ++ Start from
interdental
papilla
Pedunculated to
sessile masses
H/P: cellular fibroblastic
tissue containing
rounded
or lobulated masses of
calcified cementum-like
tissue
Calcifying fibroblastic
granuloma
Excision of lesion
RP + Ulcerated, smooth,
and pedunculated
mass
H/P: discontinuous
hyperplastic
parakeratinized stratified
squamous epithelium
and endothelial cells in
the connective tissue
Pyogenic granuloma Excision of lesion
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Pr-Bl-
Br
Soft ++ Sessile or
pedunculated tumor-
like process
H/P: multinucleated
giant cell forming
granuloma
Peripheral giant cell
granuloma
Surgical excision
W Corrugated
or
verrucous
surface
+ Non-removable
white spot
Tissue biopsy. Vital
staining with toluidine
blue and cytobrush
techniques.
H/P: dysplastic cells with
++ hyperchromatic
nuclei, cellular and
nuclear pleomorphism,
an ++
nucleo-cytoplasmic ratio,
and generalized loss of
cellular polarity and
orientation
History of tobacco/
alcohol intake
Leukoplakia Surgical excision/
cryosurgery and laser
ablation
R Velvety + Sharply demarcated
from surrounding
mucosa
Same as above May be associated
with oral lichen
planus
Erythroplakia Same as above
R- W
patches
No change Soft Smooth ++ Involve
keratinized
gingiva
Painless exophytic
mass with nonhealing
ulceration
Dysplastic changes seen
in the epithelium and
extending into
connective tissue and the
presence of keratin pearls
History of tobacco/
alcohol intake
Squamous cell
carcinoma
Surgical removal,
chemotherapy
RP No change Soft and
edematous
Smooth ++ Pallor of oral mucosa,
pain, petechiae,
ecchymosis, gingival
bleeding, deep
punched out ulcers
Blood investigation.
Bone marrow biopsy.
Tooth mobility
Dysphagia, facial
paralysis,
paraesthesia of the
face, lips, tongue,
and chin, trismus
sometimes
Leukemia Monitoring of the
patient for infection
during neutropenic
periods and early
management of
infection.
Corticosteroids,
adrenocorticotropin, or
testosterone modulates
the sharp reduction in
marrow function.
Granulocyte colony-
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stimulating factor (G-
CSF)
P Rounded Soft Smooth ++ Histopathology will show
Reed-Sternberg cells
Swollen lymph
nodes
Lymphoma Radiation and
chemotherapy plus
doxorubicin,
bleomycin, vincristine,
and dacarbazine for
Hodgkin’s lymphoma
and cyclophosphamide,
vincristine, and
prednisone for non-
Hodgkin’s
W
plaques
No change Soft Loss of stippling + Seen on facial
attached gingiva
Leukoplakia-like
asymptomatic plaque
H/P: dense fibrous
connective tissue
Frictional keratosis Prevention of deleterious
habits
RP No change Soft and
friable
— Gingival
recession
Superficial and
horizontal gingival
laceration
Not much significant Toothbrushing-induced
gingival ulceration
Changing the brushing
technique
R-W — Surface slough or
ulceration
Not much significant Chemical insult due to
etching, chlorhexidine,
hydrogen peroxide,
acetylsalicylic acid,
dentifrice, detergent,
calcium hydroxide, etc.
Removal of offending
irritant
R — Erythematous lesion
that slough a
coagulated surface,
vesicles and
ulceration may be
present
Not of much significance Burns of mucosa Supportive care and
hydration
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Br-Bl No change No change No change = Pigmented deposits in
the epithelium and
connective tissue
Addison’s disease,
Albright syndrome,
Peutz-Jeghers
syndrome
Gingival pigmentation Not required
Br No change Firm No change = Mandibular
facial gingiva
H/P: pigmented macules
seen in section
Smoker’s melanosis Smoking cessation for
2 weeks
Bl-
Gy–Br-
Bl
No change No change No change = Diffuse pigmentation Drug-induced
pigmentation
(antimalarial,
minocycline)
Cessation of drug if
required
Bl-
Gy–Br-
Bl
No change No change No change = H/P: discrete granules in
connective tissue
Amalgam tattoo Removal of amalgam
debris and replacement
of amalgam if required
C, color; Cr, contour; Cs, consistency; T, texture; S, size; P, position; L, lesion; lab and H/P, laboratory procedures and histopathology; add sym, additional symptoms; D, diagnosis; Rx, treatment; FR, fiery red; G, same as surrounding
gingiva; W, white; PR, pink to reddish; B-Br, black to brown; R-Gy, red to gray; RP, reddish pink; BR, bright red; Pi, pink; Pl, pale pink; Pr, purple; Bl, blue; OHI, oral hygiene instruction; CHX, chlorhexidine; +, slightly increased; ++,
increased; , slightly decreased; , decreased; /+, may increase or decrease; =, remains the same.
Table 4.
Clinical features for diagnosis and treatment of non-plaque-induced gingival diseases.
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3. Treatment of gingival disease
The treatment of gingival disease is based on resolving the etiologic factors and
maintaining the systemic status of the individual. In the case of plaque-induced
gingivitis, the main treatment plan involves removal of plaque and calculus by
scaling and root planning, followed by oral hygiene instruction which includes
modified bass method of brushing and the use of chemical plaque control agents
like 0.2% or 0.02% chlorhexidine gluconate or essential oil mouthwash. In cases of
gingival enlargement, initial therapy is focused on removing plaque and calculus,
followed by a review on the gingival condition; only if the condition does not
improve the drug substitution may be considered, followed by gingivectomy to
remove the enlarged gingival tissue. Plaque-induced gingival disease influenced by
modifying factors is controlled by reducing the exposure of the modifying factor in
addition to removal of plaque and calculus to maintain oral hygiene. The details of
the treatment have been mentioned in Table 2. Non-plaque-induced gingival dis-
eases are treated depending on the etiology of the gingival disease. For example,
viral lesions are treated by providing antiviral medications in addition to oral
hygiene instruction. The details of treatment in brief are mentioned in Table 4.
Diagnosis is essential for providing the proper treatment plan and updating recent
research which might help prevent undue treatment [8].
4. Conclusions
Gingival diseases are an initial starting point of the advanced periodontal disease
and in some cases depict the manifestation of an underlying undiagnosed systemic
condition. Therefore, the early diagnosis of gingival disease and its treatment are
warranted.
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